• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/19/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported by customer that over the past few weeks there have been multiple failures of the bd power loc max mediport needle.The failures occur in the tubing causing a leak.Results in both drug loss and blood exposure.No other information was provided.It was reported this occurred with 3 devices.This report addresses all 3 devices.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The device has not been returned to the manufacturer for evaluation.
 
Event or Problem Description
It was reported by customer that over the past few weeks there have been multiple failures of the bd power loc max mediport needle.The failures occur in the tubing causing a leak.Results in both drug loss and blood exposure.No other information was provided.It was reported this occurred with 3 devices.This report addresses all 3 devices.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The initial complaint was submitted with (b)(6) 2024 as the date of awareness.After further review, it was determined the date of awareness for this event is 20 september 2024.The manufacturer has received the sample and will be evaluated.A supplemental will be submitted with evaluation results.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The date of awareness for this complaint is september 20, 2024.The date of occurrence for this complaint is september 19, 2024.The complaint of leak was confirmed.The product returned for evaluation was one 20g powerloc max infusion set w/y-site.The returned product sample was evaluated and the following observations were made: ¿ a tear in the extension tube was observed at the interface of the y-site the fracture surfaces of the damage contained striation-like patterns which were indicative of flexural fatigue based failures, which may have been a contributing factor to the extension tubing damage.Repetitive mechanical stresses such as twisting and kinking may have contributed to the observed event; however, it appeared that additional unidentified factors also contributed.The device is a supplied component and the supplier has been notified of this event.This complaint will be recorded for future trending and monitoring purposes.
 
Event or Problem Description
It was reported by customer that over the past few weeks there have been multiple failures of the bd power loc max mediport needle.The failures occur in the tubing causing a leak.Results in both drug loss and blood exposure.No other information was provided.It was reported this occurred with 3 devices.This report addresses all 3 devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
maddy vincent
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key20482320
Report Number3006260740-2024-05997
Device Sequence Number4095606
Product Code FPA
UDI-Device Identifier00801741047374
UDI-Public(01)00801741047374(11)231216(17)260715(10)ASHUFC077
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/28/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/15/2026
Device Model NumberN/A
Device Catalogue Number0132075
Device Lot NumberASHUFC077
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/20/2024
Supplement Date Received by Manufacturer11/05/2024
01/28/2025
Initial Report FDA Received Date10/18/2024
Supplement Report FDA Received Date11/26/2024
02/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-